# Kent Davies

> From window films to boardrooms, Kent Davies has spent his career working on the practical side of growth. At ARCHIMED, the former company chief brings that experience to the relationship between owners and operators.

- **Role:** Operating Partner & Portfolio Company Board Chair at ARCHIMED
- **Organizations:** ARCHIMED, PDI, Haemonetics, RoundTable III Platform Development Corporation, Gaymar Industries, Solutia / CPFilms, United Industries, Kimberly-Clark, 3M, General Mills, Irrimax, ZimVie
- **Education:** BA in History, University of California, Berkeley, MBA in Marketing, University of Minnesota, Finance coursework, The Wharton School, University of Pennsylvania
- **Known for:** Led Gaymar as CEO at the time of its announced approximately $150 million acquisition by Stryker., Held enterprise-wide commercial, operational and financial responsibility as PDI President and COO., Led CPFilms as president and served as a corporate officer at Solutia.

## Career timeline

- **Before 2006** — Held sales roles at General Mills, product roles at 3M, general management and marketing roles at Kimberly-Clark, and a senior vice president role at United Industries.
- **2006** — Appointed senior vice president of Solutia and president of CPFilms.
- **2009** — Left Solutia effective May 1; his public recommendation of Jim Buccini describes taking a CEO role in mid-2009.
- **2010** — CEO of Gaymar when Stryker announced an approximately $150 million all-cash acquisition agreement.
- **Before May 2014** — CEO of RoundTable III Platform Development Corporation, identifying and developing investment opportunities.
- **2014** — Haemonetics announced his appointment as President, Global Markets, effective May 12.
- **2015** — Promoted to Chief Operating Officer of Haemonetics in April.
- **2017** — PDI appointed him President and Chief Operating Officer on October 4.
- **2022** — Accepted a New Jersey proclamation with PDI CEO Zachary Julius recognizing the company’s community-giving day.
- **2024** — Joined Irrimax’s board in September, according to his public LinkedIn profile.
- **2025** — Became Irrimax board chair in February and joined ZimVie’s board in October, according to his public LinkedIn profile.

## Achievements

- Led Gaymar as CEO at the time of its announced approximately $150 million acquisition by Stryker.
- Held enterprise-wide commercial, operational and financial responsibility as PDI President and COO.
- Led CPFilms as president and served as a corporate officer at Solutia.
- Advanced from President, Global Markets to COO at Haemonetics.

## Latest updates

- **—** — In a public LinkedIn post, Davies described portfolio reviews in Lyon and preparations for ARCHIMED’s annual meeting in Berlin; the displayed relative date does not establish an exact publication month.
- **2025-10** — His public LinkedIn profile records joining ZimVie’s board.

## Links

- Website: https://www.archimed.group/
- LinkedIn: https://www.linkedin.com/in/kentdavies

---

Profile page: https://yespress.io/kent-davies
Published by YesPress — https://yespress.io
Last updated: 2026-10-10